What they were paid
AbCellera Biologics Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $0 | — | $0 | — |
| FY2024 | — | — | — | $0 | — |
| FY2022 | — | $0 | — | $0 | — |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbCellera Biologics Inc. DEF 14A filed April 29, 2026, accession 0001703057-26-000020, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025AbCellera Biologics pays directors a $50,000 cash retainer and $400,000 in Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance
The rest of the AbCellera Biologics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carl L.G. Hansen | Director | $0 |
| John S. Montalbano | Independent Director | $558,861 |
| Stephen R. Quake | Independent Director | — |
| Véronique Lecault | Director | $0 |
The full AbCellera Biologics compensation record
free company briefThis page is one director within AbCellera Biologics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat